Mentions
Extended reach
Total likes
Video views
AI synopsis
Many discussions emphasize the effectiveness of high-dose cholecalciferol, with phrases like 'significantly reduced disease activity' and 'these results warrant further investigation' creating a tone of optimism and urgency. Additionally, users reference the study's methodology and advocate for further research, showcasing both good understanding and concern over broader implications of vitamin D in MS treatment.
The majority of posts express strong support for the findings of the trial, highlighting the reduced disease activity associated with high-dose vitamin D.
Discussions indicate a high level of curiosity and relevance, with many contributors eager to learn more about the implications of the study.
Participants refer to specific findings and clinical implications, showing deep engagement with the topic and the research methodologies used.
Most users perceive the study as potentially transformative for treatment approaches to multiple sclerosis, suggesting significant future implications.
El colecalciferol oral a dosis de 100,000 UI cada 2 semanas redujo significativamente la actividad de la enfermedad en el síndrome clínico aislado y en la esclerosis múltiple recurrente-remitente en sus etapas iniciales. JAMA 2025; DOI: 10.1001/jama.2025.1604 https://t.co/FVn3mrRfmY
Oral high-dose vitamin D reduced disease activity in patients with clinically isolated syndrome and in early relapsing-remitting multiple sclerosis. https://t.co/pYeaDm5WBM
Can vitamin D reduce disease activity in patients with clinically isolated syndrome that typically precedes #MultipleSclerosis and early relapsing-emitting #MS? #MSAwarenessWeek Learn more: https://t.co/FDxqIJ8WZp https://t.co/jr2M1QANLn
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis Supplements of vitamin D could be an effective treatment for the neurodegenerative condition multiple sclerosis. https://t.co/eaDp6bgfRa @DHPSP @dronita_de @guani_vic @drfherediaz @DrGrimaldesJ
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial jamanetwork.com/journals/jam...
Can vitamin D actually slow the progression of multiple sclerosis? A 2025 JAMA trial confirms it does! In patients with early-stage MS, those receiving 100,000 IU of vitamin D biweekly showed a 34% reduction in disease…
This video discusses 5 recent studies from 2024-2025 that enhance our understanding of multiple sclerosis (MS). Topics include the impact of genetics, menopause, high-dose vitamin D, Mediterranean diet, and physical…
RT @AmbrizMau: El colecalciferol oral a dosis de 100,000 UI cada 2 semanas redujo significativamente la actividad de la enfermedad en el sí…
RT @NutrioSci: High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial #…
RT @NutrioSci: High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial #…
RT @NutrioSci: High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial #…
RT @NutrioSci: High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial #…
RT @NutrioSci: High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial #…
RT @NutrioSci: High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial #…
RT @NutrioSci: High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial #…
RT @NutrioSci: High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial #…
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial #Meded #MedX #TIC2025 https://t.co/atMtsol9T5 https://t.co/Ob2T3pHX6w
RT @IJMSCtweets: "Oral #cholecalciferol 100 000 IU every 2 weeks significantly reduced disease activity in #CIS & early relapsing-remitting…
RT @IJMSCtweets: "Oral #cholecalciferol 100 000 IU every 2 weeks significantly reduced disease activity in #CIS & early relapsing-remitting…
"Oral #cholecalciferol 100 000 IU every 2 weeks significantly reduced disease activity in #CIS & early relapsing-remitting #MultipleSclerosis. These results warrant further investigation, including potential role of pulse high-dose vitamin D..." https://t.co/k0KeOCZGpv https://t.co/ryuRTFSW0z
Ref.: doi:10.1001/jama.2025.1604
Not that big of a theoretical leap to believe this hormonally active vitamin has other anti-inflammatory and disease modulating effects Link: https://t.co/A13ioBVPf7
https://t.co/rZIW6cnDFK
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple SclerosisThe D-Lay MS Randomized Clinical Trial. https://t.co/Tec9kn9L1H
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis The D-Lay MS Randomized Clinical Trial. https://t.co/Tec9kn9L1H
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple SclerosisThe D-Lay MS Randomized Clinical Trial https://t.co/Tec9kn9L1H
RT @beckerbarroso: High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis https://t.co/MiP7dPuIG1
Sube el precio de la vitamina D High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis https://t.co/d3D648GrW8
RT @3stars67664378: 多発性硬化症に対する
RT @FarmaMadridAP: (JAMA) Vitamina D en dosis altas en el síndrome clínicamente aislado (SCA) típico de la esclerosis múltiple: en este ens…
RT @FarmaMadridAP: (JAMA) Vitamina D en dosis altas en el síndrome clínicamente aislado (SCA) típico de la esclerosis múltiple: en este ens…
Hochdosis Vitamin D reduzierte in kleiner Studie die Anzahl der erneuten Schübe bei "klinisch isoliertem Syndrom". Die Ergebnisse sollten in einer größeren Studie repliziert werden, machen aber Hoffnung. #MultipleSklerose, #CIS, #KIS https://t.co/PE3jvyVO8q
فعالیت بیماری رو توی تصویربرداری مغز کاهش بده، بدون اینکه عوارض جدیای ایجاد کنه. https://t.co/O9svEM8nPq
(JAMA) Vitamina D en dosis altas en el síndrome clínicamente aislado (SCA) típico de la esclerosis múltiple: en este ensayo clínico aleatorizado se redujo la actividad de la enfermedad en el SCA y en la esclerosis múltiple recurrente-remitente temprana https://t.co/NTKClUWKnr
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple SclerosisThe D-Lay MS Randomized Clinical Trial jamanetwork.com/journals/jam...
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple SclerosisThe D-Lay MS Randomized Clinical Trial https://t.co/Tec9kn9L1H
JAMA (March 2025): "Oral high-dose cholecalciferol (vitamin D) reduced disease activity in clinically isolated syndrome and in early relapsing-remitting multiple sclerosis" https://t.co/r3x0EYuITZ
多発性硬化症に対する
Interesting study. High doses of vitamin D appear to help with MS. https://t.co/BeUWq4Xppd
RT @JAMA_current: Oral high-dose vitamin D reduced disease activity in patients with clinically isolated syndrome and in early relapsing-re…
"High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis The D-Lay MS Randomized Clinical Trial." Publié ce jour dans @jama.com #MedSky #NeuroSky jamanetwork.com/journals/jam...
RT @JAMA_current: Oral high-dose vitamin D reduced disease activity in patients with clinically isolated syndrome and in early relapsing-re…
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial | Demyelinating Disorders | JAMA | JAMA Network https://t.co/x7AFezPFbz
RT @JAMA_current: Oral high-dose vitamin D reduced disease activity in patients with clinically isolated syndrome and in early relapsing-re…
RT @JAMA_current: Oral high-dose vitamin D reduced disease activity in patients with clinically isolated syndrome and in early relapsing-re…
RT @JAMA_current: Oral high-dose vitamin D reduced disease activity in patients with clinically isolated syndrome and in early relapsing-re…
RT @JAMA_current: Oral high-dose vitamin D reduced disease activity in patients with clinically isolated syndrome and in early relapsing-re…
Oral high-dose vitamin D reduced disease activity in patients with clinically isolated syndrome and in early relapsing-remitting multiple sclerosis. https://t.co/pYeaDm5WBM
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis https://t.co/6caNmRGHM5
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis https://t.co/VJyS0hfU7g. This does not work in dark-skinned individuals.
There are now many trials demonstrating the effectiveness of high doses of Vitamin D against diseases. Here's one. 50,000 units per week Vitamin D in Clinically Trial of Multiple Sclerosis in a Randomized Clinical Trial. https://t.co/ls52pypyyz
RT @_MCRicardo_: High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis Supplements of vitamin D could be an ef…
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis https://t.co/P3N79tixpF
RT @IsilDr22: Yeni çalışma: Yüksek doz D vitamini izole klinik sendromu olan ve erken relaps Multipl skleroz hastalarında hastalık aktivite…
Yeni çalışma: Yüksek doz D vitamini izole klinik sendromu olan ve erken relaps Multipl skleroz hastalarında hastalık aktivitesini azalttı. https://t.co/skxCR5PyNt
@avsangies https://t.co/N1YC19P6Mj
RT @_MCRicardo_: High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis Supplements of vitamin D could be an ef…
https://t.co/CHlYzdF532
Oral cholecalciferol 100 000 IU every 2 weeks significantly reduced disease activity in CIS and early relapsing-remitting MS. These results warrant further investigation, including the potential role of pulse high-dose vitamin D as add-on therapy. https://t.co/Tec9kn9L1H
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple SclerosisThe D-Lay MS Randomized Clinical Trial. https://t.co/Tec9kn9L1H
RT @_MCRicardo_: High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis Supplements of vitamin D could be an ef…
RT @_MCRicardo_: High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis Supplements of vitamin D could be an ef…
RT @_MCRicardo_: High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis Supplements of vitamin D could be an ef…
RT @_MCRicardo_: High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis Supplements of vitamin D could be an ef…
RT @_MCRicardo_: High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis Supplements of vitamin D could be an ef…
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis Supplements of vitamin D could be an effective treatment for the neurodegenerative condition multiple sclerosis. https://t.co/eaDp6bgfRa @DHPSP @dronita_de @guani_vic @drfherediaz @DrGrimaldesJ
https://t.co/wGiIsrSMzN
RT @cjbakermd: Vitamin D for the win again! Mainstream medicine is begrudgingly starting to acknowledge the value in Vit D, including agai…
RT @cjbakermd: Vitamin D for the win again! Mainstream medicine is begrudgingly starting to acknowledge the value in Vit D, including agai…
RT @cjbakermd: Vitamin D for the win again! Mainstream medicine is begrudgingly starting to acknowledge the value in Vit D, including agai…
RT @cjbakermd: Vitamin D for the win again! Mainstream medicine is begrudgingly starting to acknowledge the value in Vit D, including agai…
Vitamin D for the win again! Mainstream medicine is begrudgingly starting to acknowledge the value in Vit D, including against MS! High-Dose Vitamin D in Syndrome Typical of Multiple Sclerosis @Honest_Medicine @NicHulscher @RobertKennedyJr @drdrew https://t.co/e7ZA3ah1if
RT @agingdoc1: High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis The D-Lay MS Randomized Clinical Trial "…
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis The D-Lay MS Randomized Clinical Trial "Oral high-dose cholecalciferol reduced disease activity in clinically isolated syndrome and in early relapsing-remitting multiple sclerosis." https://t.co/p21FFy9qOt
RT @erlesen: High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple SclerosisThe D-Lay MS Randomized Clinical Trial https:…
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis https://t.co/FpZ00pdawy
RT @erlesen: High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple SclerosisThe D-Lay MS Randomized Clinical Trial https:…
RT @NutrioSci: High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial h…
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple SclerosisThe D-Lay MS Randomized Clinical Trial jamanetwork.com/journals/jam... Clinical trial: High‑dose vitamin D significantly reduces disease activity in early multiple sclerosis onset medicalxpress.com/news/2025-03...
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple SclerosisThe D-Lay MS Randomized Clinical Trial https://t.co/QyRfEBsWjp Clinical trial: High‑dose vitamin D significantly reduces disease activity in early multiple sclerosis onset https://t.co/KzePLd1Zba
Vitamine D et SEP. Bon article pour la LCA des externes! High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis https://t.co/NbHRsglyeZ
And the JAMA Article... High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial | Demyelinating Disorders | JAMA | JAMA Network https://t.co/GeF2oQJlmi
RT @Med58ll: Vitamine D 100 000 IE elke 2 weken verminderde de ziekteactiviteit significant bij CIS en vroege recidiverende-remitterende MS…
Vitamine D 100 000 IE elke 2 weken verminderde de ziekteactiviteit significant bij CIS en vroege recidiverende-remitterende MS. Deze resultaten rechtvaardigen verder onderzoek, waaronder de rol van pulshooggedoseerde vitamine D als add-on therapie. https://t.co/eJ8YCP0Asr
RT @NutrioSci: High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial h…
RT @agingdoc1: High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial
RT @agingdoc1: High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial
“High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis The D-Lay MS Randomized Clinical Trial.” Publié en mars dans @jama.com. #MedSky #NeuroSky jamanetwork.com/journals/jam...
RT @ULLR64_1: CIS 316人を対象に、高用量ビタミンD (10万 IU、2週間毎24ヶ月投与) の有効性を評価したフランスのRCT (D-Lay MS試験）。 再発またはMRIの疾患活動のリスクはビタミンD群で34%低下した。MRIでの新規病巣や造影病巣は少なか…
RT @JAMA_current: Can vitamin D reduce disease activity in patients with clinically isolated syndrome that typically precedes #MultipleScle…
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis https://t.co/MiP7dPuIG1
RT @JAMA_current: Can vitamin D reduce disease activity in patients with clinically isolated syndrome that typically precedes #MultipleScle…
RT @JAMA_current: Can vitamin D reduce disease activity in patients with clinically isolated syndrome that typically precedes #MultipleScle…
CIS 316人を対象に、高用量ビタミンD (10万 IU、2週間毎24ヶ月投与) の有効性を評価したフランスのRCT (D-Lay MS試験）。 再発またはMRIの疾患活動のリスクはビタミンD群で34%低下した。MRIでの新規病巣や造影病巣は少なかったが、再発率や身体機能の悪化に有意差はなかった。https://t.co/g8MR7Q1HZf
RT @JAMA_current: Can vitamin D reduce disease activity in patients with clinically isolated syndrome that typically precedes #MultipleScle…
RT @JAMA_current: Can vitamin D reduce disease activity in patients with clinically isolated syndrome that typically precedes #MultipleScle…
RT @JAMA_current: Can vitamin D reduce disease activity in patients with clinically isolated syndrome that typically precedes #MultipleScle…
RT @JAMA_current: Can vitamin D reduce disease activity in patients with clinically isolated syndrome that typically precedes #MultipleScle…
Can vitamin D reduce disease activity in patients with clinically isolated syndrome that typically precedes #MultipleSclerosis and early relapsing-emitting #MS? #MSAwarenessWeek Learn more: https://t.co/FDxqIJ8WZp https://t.co/jr2M1QANLn
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial | Demyelinating Disorders | JAMA | JAMA Network https://t.co/VTz3sTblLs
RT @NatRevNeurol: "Oral high-dose cholecalciferol reduced disease activity in clinically isolated syndrome and in early relapsing-remitting…
RT @NutrioSci: High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial h…
RT @JCrippsSciGuy: “Oral cholecalciferol 100 000 IU every 2 weeks significantly reduced disease activity in CIS and early relapsing-remitti…
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial. https://t.co/wJUeIXd0KS
RT @JCrippsSciGuy: “Oral cholecalciferol 100 000 IU every 2 weeks significantly reduced disease activity in CIS and early relapsing-remitti…
RT @JCrippsSciGuy: “Oral cholecalciferol 100 000 IU every 2 weeks significantly reduced disease activity in CIS and early relapsing-remitti…
RT @AmbrizMau: El colecalciferol oral a dosis de 100,000 UI cada 2 semanas redujo significativamente la actividad de la enfermedad en el sí…
RT @JCrippsSciGuy: “Oral cholecalciferol 100 000 IU every 2 weeks significantly reduced disease activity in CIS and early relapsing-remitti…
“Oral cholecalciferol 100 000 IU every 2 weeks significantly reduced disease activity in CIS and early relapsing-remitting MS”13.8%ARR @SMHP @FatEmperor @BrianLenzkes @NutritionNetwrk @DoctorTro @LDLSkeptic @DavidPerlmutter @lowcarbusa @drmclphillips https://t.co/DQ8K4QK2Bi
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis https://t.co/XESAP4ye7d
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial | Demyelinating Disorders | JAMA | JAMA Network https://t.co/LMeMvfPe24
RT @AmbrizMau: El colecalciferol oral a dosis de 100,000 UI cada 2 semanas redujo significativamente la actividad de la enfermedad en el sí…
pubmed.ncbi.nlm.nih.gov/40063041/ #MultipleSclerosis
☀️ Oral vitamin D☀️supplements (cholecalciferol) at a dose of 100 000 IU every 2 weeks significantly reduced disease activity in patients with early (CIS/RRM) Multiple Sclerosis. https://t.co/AwHotIBJ5K
(JAMA) Seguridad y eficacia de la administración de altas dosis de vit D en el síndrome clínicamente aislado típico de la esclerosis múltiple https://t.co/q610VUtMPb ECA https://t.co/ZUE3luylp5
RT @NatRevNeurol: "Oral high-dose cholecalciferol reduced disease activity in clinically isolated syndrome and in early relapsing-remitting…
RT @AmbrizMau: El colecalciferol oral a dosis de 100,000 UI cada 2 semanas redujo significativamente la actividad de la enfermedad en el sí…
RT @IJMSCtweets: JAMA: "Oral #cholecalciferol 100 000 IU every 2 weeks significantly reduced disease activity in #CIS & early relapsing-rem…
RT @IJMSCtweets: JAMA: "Oral #cholecalciferol 100 000 IU every 2 weeks significantly reduced disease activity in #CIS & early relapsing-rem…
JAMA: "Oral #cholecalciferol 100 000 IU every 2 weeks significantly reduced disease activity in #CIS & early relapsing-remitting #MS. These results warrant further investigation, including potential role of pulse high-dose #VitaminD as add-on therapy." https://t.co/01qZmSqkHy https://t.co/PXC2kDAmSV
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial | Demyelinating Disorders | JAMA | JAMA Network https://t.co/VTz3sTblLs
RT @AmbrizMau: El colecalciferol oral a dosis de 100,000 UI cada 2 semanas redujo significativamente la actividad de la enfermedad en el sí…
2/ Incluso en caso de niveles insuficientes, la vitamina D tiene un efecto beneficioso. https://t.co/Ne4Faysm8h
RT @AmbrizMau: El colecalciferol oral a dosis de 100,000 UI cada 2 semanas redujo significativamente la actividad de la enfermedad en el sí…
El colecalciferol oral a dosis de 100,000 UI cada 2 semanas redujo significativamente la actividad de la enfermedad en el síndrome clínico aislado y en la esclerosis múltiple recurrente-remitente en sus etapas iniciales. JAMA 2025; DOI: 10.1001/jama.2025.1604 https://t.co/FVn3mrRfmY
RT @NutrioSci: High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial h…
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial https://t.co/atMtsokC3x https://t.co/5zIMSxmM5e
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial jamanetwork.com/journals/jam...
RT @NatRevNeurol: "Oral high-dose cholecalciferol reduced disease activity in clinically isolated syndrome and in early relapsing-remitting…
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis https://t.co/gYvlPMcBHB
So promising! https://t.co/kGbSj0iPxT
"Oral high-dose cholecalciferol reduced disease activity in clinically isolated syndrome and in early relapsing-remitting multiple sclerosis" https://t.co/T6HBzoQKd7
Hochdosiertes Vitamin D in der Frühphase der MS wirksam https://t.co/PE3jvyVgiS
RT @AbbateAntonio: High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis https://t.co/NzCM9fdm0o fascinating
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis https://t.co/MeTIAY9WKD
RT @Carcos2: This RCT showed the efficacy and low risk of adverse events of oral cholecalciferol 100 000IU monotherapy every 2 weeks to red…
This RCT showed the efficacy and low risk of adverse events of oral cholecalciferol 100 000IU monotherapy every 2 weeks to reduce disease activity in patients with clinically isolated syndrome for multiple sclerosis and early RRMS ¿Qué hacemos @rafabravo? https://t.co/wg8WYT1ate
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple SclerosisThe D-Lay MS Randomized Clinical Trial https://t.co/Tec9kn9L1H
RT @JAMA_current: Oral high-dose vitamin D reduced disease activity in patients with clinically isolated syndrome and in early relapsing-re…
RT @JAMA_current: Oral high-dose vitamin D reduced disease activity in patients with clinically isolated syndrome and in early relapsing-re…
RT @JAMA_current: Oral high-dose vitamin D reduced disease activity in patients with clinically isolated syndrome and in early relapsing-re…
RT @JAMA_current: Oral high-dose vitamin D reduced disease activity in patients with clinically isolated syndrome and in early relapsing-re…
RT @JAMA_current: Oral high-dose vitamin D reduced disease activity in patients with clinically isolated syndrome and in early relapsing-re…
RT @JAMA_current: Oral high-dose vitamin D reduced disease activity in patients with clinically isolated syndrome and in early relapsing-re…
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis https://t.co/NzCM9fdm0o fascinating
RT @JAMA_current: Oral high-dose vitamin D reduced disease activity in patients with clinically isolated syndrome and in early relapsing-re…
RT @JAMA_current: Oral high-dose vitamin D reduced disease activity in patients with clinically isolated syndrome and in early relapsing-re…
RT @JAMA_current: Oral high-dose vitamin D reduced disease activity in patients with clinically isolated syndrome and in early relapsing-re…
RT @JAMA_current: Oral high-dose vitamin D reduced disease activity in patients with clinically isolated syndrome and in early relapsing-re…
RT @JAMA_current: Oral high-dose vitamin D reduced disease activity in patients with clinically isolated syndrome and in early relapsing-re…
RT @JAMA_current: Oral high-dose vitamin D reduced disease activity in patients with clinically isolated syndrome and in early relapsing-re…
RT @JAMA_current: Oral high-dose vitamin D reduced disease activity in patients with clinically isolated syndrome and in early relapsing-re…
RT @JAMA_current: Oral high-dose vitamin D reduced disease activity in patients with clinically isolated syndrome and in early relapsing-re…
Vitamina D em altas doses na esclerose múltipla. https://t.co/7GqG55GA4V
RT @JAMA_current: Oral high-dose vitamin D reduced disease activity in patients with clinically isolated syndrome and in early relapsing-re…